Burke & Herbert Bank & Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History

Burke & Herbert Bank & Trust’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$422K	Sell	3,860 -160	-4%	-$16.6K	0.1%	164
2026 Q1	$418K	Hold	4,020	–	–	0.12%	155
2025 Q4	$415K	Sell	4,020 -4,655	-54%	-$453K	0.11%	154
2025 Q3	$784K	Sell	8,675 -190	-2%	-$16.6K	0.17%	135
2025 Q2	$780K	Hold	8,865	–	–	0.17%	136
2025 Q1	$808K	Hold	8,865	–	–	0.19%	128
2024 Q4	$765K	Buy	8,865 +65	+0.7%	+$5.88K	0.18%	134
2024 Q3	$836K	Buy	8,800 +2,315	+36%	+$220K	0.19%	129
2024 Q2	$593K	Buy	+6,485	New	+$579K	0.14%	143

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Burke & Herbert Bank & Trust's PPH Position: Q2 2026 in Review

Burke & Herbert Bank & Trust reduced its VanEck Pharmaceutical ETF (PPH) stake by 4% in Q2 2026, selling an estimated $16.6K and leaving 3,860 shares worth $422K. The position accounts for 0.1% of the portfolio, ranked #164.

Burke & Herbert Bank & Trust first reported a position in PPH in Q2 2024 and has held it in 9 quarters since. The position peaked at $836K in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Burke & Herbert Bank & Trust held 3,860 shares of VanEck Pharmaceutical ETF worth $422K as of Q2 2026.
Burke & Herbert Bank & Trust sold 160 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $16.6K.
VanEck Pharmaceutical ETF made up 0.1% of Burke & Herbert Bank & Trust's portfolio in Q2 2026, its #164 holding.
Burke & Herbert Bank & Trust first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 9 quarters since.
Burke & Herbert Bank & Trust's VanEck Pharmaceutical ETF position peaked at $836K in Q3 2024.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Burke & Herbert Bank & Trust's 13F filing for Q2 2026, filed 7 Aug 2026.